CMS Issues Guidance For Medicare Drug Inflation Rebates
The U.S. Centers for Medicare and Medicaid issued revised guidance for its Medicare prescription drug inflation rebate program that addresses how it calculates rebates for drug shortages and announced that 48...To view the full article, register now.
Already a subscriber? Click here to view full article